Life sciences will be at the top of investors’ list
Shu Joshi, Managing Partner, LSV Capital Partners explains how the novel coronavirus pandemic has enabled us to look at things…
Author
Renewing commitment towards life sciences
The life sciences industry needs to relook and redraw its strategies to truly fulfil its core duty of ensuring the wellbeing of…
Workplace management in the new normal
Sumeet Doshi, Country Manager, India, Kronos Incorporated explains how modern workforce management tools can optimise employee…
The new norm will be supply chain stress tests to build resilience
The COVID-19 crisis has thrown up unprecedented challenges and opportunities for the Indian pharma sector. Dr Arun Singh, Chief…
Open Science: Key to combat zoonosis
Largely opaque and proprietary R&D environments in the life sciences sector need to make way for strategies facilitated by…
Pharma workforce post COVID-19
Experts share some of the most immediate and important changes that will be reflected in the pharma workforce and its management…
Dak, Dawa aur Dua: A Made in India story
The alliance between India Post and India Pharma Inc is an interesting example of how intersectoral collaborations can optimise…
Computational methodologies can be effective in predicting and prioritising key targets related to…
Supreet Deshpande, CEO, NovaLead Pharma shares more insights on how computational technologies can revolutionise pharma R&D…
Embracing the power of data
The pharma sector needs to improve its capabilities in data gathering and analysis with the help of AI and computational…
Fortifying defence against zoonoses
Express Pharma series on the key pillars of a strategic framework to tackle zoonotic diseases